Mai-Britt Zocca - 04 Nov 2021 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role: Chief Executive Officer, Director
Signature: /s/ Brian Burkavage, Attorney-in-Fact for Mai-Britt Zocca
Issuer symbol: IOBT
Transactions as of: 04 Nov 2021
Net transactions value: $0
Form type: 4
Filing time: 08 Nov 2021, 17:33:02 UTC
Next filing: 12 Nov 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IOBT	Stock Option (Right to Buy)	Award	$0	+414,212		$0.000000	414,212	04 Nov 2021	Common Stock	414,212	$14.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These options vest in 1/48 monthly increments of the vesting commencement date of November 4, 2021, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause or by the reporting person within 24 months of a change of control.

Content

These options vest in 1/48 monthly increments of the vesting commencement date of November 4, 2021, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause or by the reporting person within 24 months of a change of control.